Chesnara Plc: Fourth acquisition in two years
12 November 2026
Rapport Therapeutics, Inc. (RAPP), a burgeoning player in the biotechnology sector, has caught the attention of investors with a significant potential upside of 80.08%. The company’s..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage pharmaceutical company, is gaining attention among investors with its promising pipeline of treatments for neurodegenerative diseases and a notable..
Septerna, Inc. (NASDAQ: SEPN), an emerging player in the biotechnology industry, is garnering attention with its impressive potential upside of 79.58%, according to analyst ratings. This..
In the ever-evolving landscape of biotechnology, PureTech Health plc (NASDAQ: PRTC) stands out as a dynamic player with a focus on groundbreaking biopharmaceutical solutions. Despite a..
Prothena Corporation plc (NASDAQ: PRTA), an emerging player in the biotechnology sector, is currently positioned at an intriguing juncture with a market capitalization of approximately $512.49..
Kamada Ltd. (NASDAQ: KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, stands out in the drug manufacturing sector with a promising investment outlook. The..
Abivax SA (NASDAQ: ABVX), a French biotechnology firm, is gaining attention from investors with a significant potential upside of 41.76% as indicated by current analyst ratings...
Altimmune, Inc. (NASDAQ: ALT) has emerged as a compelling investment opportunity within the biotechnology sector, particularly for those interested in high-growth potential stocks in the healthcare..
AbCellera Biologics Inc. (NASDAQ: ABCL) is a Canadian biotechnology company making waves in the healthcare sector with its innovative approach to antibody-based medicine development. With a..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company focused on precision medicine, is capturing the attention of investors with its promising pipeline and significant upside..
KalVista Pharmaceuticals, Inc. (KALV) represents an intriguing prospect for investors looking to capitalize on opportunities within the healthcare sector, specifically in biotechnology. With a market cap..
Myriad Genetics, Inc. (NASDAQ: MYGN) remains a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Salt Lake City, Utah,..
Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector specializing in life sciences, presents a unique opportunity for investors seeking exposure to the..
AxoGen, Inc. (NASDAQ: AXGN), an emerging leader in the healthcare sector focused on peripheral nerve regeneration, stands out with a compelling investment narrative. Specializing in medical..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector with its focus on developing and commercializing innovative pain management medications. As a player in..
iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in developing MRI-compatible medical devices. With a market capitalization of $1.26 billion, this Orlando-based..
Investors seeking opportunities in the healthcare sector may find Personalis, Inc. (NASDAQ: PSNL) an intriguing prospect, especially with its considerable upside potential. Headquartered in Fremont, California,..
Taysha Gene Therapies, Inc. (TSHA), a promising player in the biotechnology sector, has caught the attention of investors with its significant potential upside of 161.24%. Operating..
Investors keen on exploring opportunities in the healthcare sector might find Treace Medical Concepts, Inc. (NASDAQ: TMCI) an intriguing candidate, given its potential upside of 232.03%,..
Ardelyx, Inc. (NASDAQ: ARDX) is drawing significant investor attention in the biotechnology sector, with a remarkable potential upside of 182.95% based on current analyst ratings. As..
